Takeda Pharmaceutical Co Ltd
TSE:4502
Takeda Pharmaceutical Co Ltd
TSE:4502
Price:
4 125 JPY
-0.43%
Updated:
May 6, 2024
Takeda Pharmaceutical Co Ltd
Interest Income Expense
|
Takeda Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison
Comparables:
4568
4578
4523
4519
4503
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Interest Income Expense
-¥164.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Interest Income Expense
¥11.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Interest Income Expense
¥25B
|
CAGR 3-Years
51%
|
CAGR 5-Years
14%
|
CAGR 10-Years
3%
|
|
|
Eisai Co Ltd
TSE:4523
|
Interest Income Expense
¥7.4B
|
CAGR 3-Years
114%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Interest Income Expense
¥4.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
Astellas Pharma Inc
TSE:4503
|
Interest Income Expense
¥1.1B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-19%
|
See Also
What is Takeda Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
-164.5B
JPY
-164.5B
JPY
Based on the financial report for Dec 31, 2023, Takeda Pharmaceutical Co Ltd's Interest Income Expense amounts to -164.5B JPY.
What is Takeda Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-20%
-20%
Over the last year, the Interest Income Expense growth was -29%. The average annual Interest Income Expense growth rates for Takeda Pharmaceutical Co Ltd have been 3% over the past three years , -20% over the past five years .
You don't have any saved screeners yet
